Recent Report Shows That Rep. French Hill Sold Up to $365K Worth of Pfizer Stock

A January filing shows that Representative French Hill reported a sale in Pfizer (NYSE:PFE), valued between $131,004 and $365,000. The transaction date is listed as December 31, 2025, with the report published on January 23, 2026.

At present, Pfizer shares are trading up 0.1% at $25.68.

Representative's Recent Trading Activity

In the past three years, French Hill made 30 stock trades totaling more than $908 thousand. The largest trades involved stocks like Philip Morris Intl and Blackstone. Their most notable trades made recently include key transactions: None

Here's a summary of French Hill's recent trades:

Want to keep up with French Hill and other congressional members' stock activities? Check out our government trades tool for real-time updates!

The Importance of Congressional Transactions

A congressional transaction is when any representative or senator either buys or sells an individual stock.

Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.

In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.

Why Congressional Transactions Matter

Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.

When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.

A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.

This article was generated by Benzinga's automated content engine and reviewed by an editor.